Status:
COMPLETED
Risk Assessment for Progression to DMEK Following Cataract Surgery in Fuchs Endothelial Corneal Dystrophy
Lead Sponsor:
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Conditions:
Fuchs' Endothelial Dystrophy
Cataract
Eligibility:
All Genders
Brief Summary
Justification. Fuchs' corneal endothelial dystrophy (FECD) is one of the main causes of corneal transplantation. In many cases, the corneal decompensation derived from this dystrophy is triggered as a...
Eligibility Criteria
Inclusion
- FECD grade 2 or worse (modified Krachmer scale)
- Cataract requiring surgery
- Epithelial corneal edema evident in slit lamp examination
Exclusion
- Concurrent anterior corneal dystrophy
- History of ocular trauma, ocular surgery, previous ocular inflammation or infection,uncotroled glaucoma, amblyopia, neovascular age-related macular degeneration, or active vacular retinal disease.
- Non-collaborative or unable to receive postoperative care at our institution.
Key Trial Info
Start Date :
July 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04072029
Start Date
July 1 2017
End Date
December 30 2019
Last Update
February 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Ramón y Cajal
Madrid, Spain, 28034